Table 1.

Clinical events, hazard ratios and nominal 95% confidence intervals associated with assignment to CEE-based hormone therapy compared to placebo reported by the Women's Health Initiative.

Clinical Event	CEE+MPA trial HR [95% CI]	CEE - Alone Trial HR [95% CI]
Stroke	1.41 [1.07-1.85]*	1.39 [1.10-1.77]*
Coronary Heart Disease	1.29 [1.07-1.85]*	0.91 [0.75-1.12]
Pulmonary Embolism	2.13 [1.39-3.25]*	1.34 [0.87-2.06]
Breast Cancer	1.25 [1.00-1.59]*	0.77 [0.59-1.01]
Death	0.98 [0.82-1.18]	1.08 [0.88-1.32]
Colorectal Cancer	0.63 [0.43-0.92]*	1.08 [0.75-1.55
Hip Fracture	0.66 [0.45-0.98]*	0.61 [0.41-0.91]*

^*95% Confidence interval excludes 1.0